RxDoctor Payments Data

David Adams, MD

Family Medicine · Hixson, TNNPI 1467463299

Payments from drug & device makers

$1,948in general payments, 2019–2025

Across 121 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$292
  • Abbott$279
  • Novo Nordisk$270
  • AstraZeneca$183
  • GSK$131
  • Amgen$107
  • plus $685 from 20 others

What the payments were for

  • Food & beverage$1,948100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,948 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$221,061
Medicare patients
451
Services billed
5,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban285$283,969
OzempicSemaglutide115$159,348
JardianceEmpagliflozin85$102,931
TrulicityDulaglutide68$85,077
MounjaroTirzepatide43$61,331
XareltoRivaroxaban47$57,012
FarxigaDapagliflozin Propanediol37$43,931
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$21,207
Repatha SureclickEvolocumab18$18,857
JanuviaSitagliptin Phosphate16$18,145
LinzessLinaclotide15$13,779
Tresiba Flextouch U-100Insulin Degludec19$11,768
Atorvastatin Calcium762$9,744
Rosuvastatin Calcium664$9,001
Breo ElliptaFluticasone/Vilanterol16$7,776

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$292$283,969285 claims
Novo NordiskOzempic$270$159,348115 claims
Lilly USA, LLCTrulicity, Mounjaro$37$146,408111 claims
Boehringer IngelheimJardiance$75$102,93185 claims
Johnson & JohnsonXarelto$33$57,01247 claims
AstraZenecaFarxiga, Symbicort$183$47,88454 claims
GSKTrelegy Ellipta, Breo Ellipta$131$28,98339 claims
AbbVieLinzess, Synthroid$24$19,52488 claims
MerckJanuvia$39$18,14516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Hixson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →